摘要
高血压是最常见的心血管疾病．也是最重要的心血管疾病危险因素。而作为心血管疾病一线用药的β受体阻滞剂对高血压的治疗地位近年来受到质疑与争论，这一方面束缚了医生与高血压患者的思想．另一方面也反映了近年来降压治疗优化选择策略的进展，因此对其应用的考虑也有重要意义。
出处
《中国医药导报》
CAS
2008年第25期164-164,共1页
China Medical Herald
参考文献3
-
1[1]Messerli FH,Grossman E,Goldbourt U.Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review[J].JAMA,1998,279:1903-1907.
-
2[2]Lindholm LH,Carlberq B,Samuelsson O.Should beta blockers remain first choice in treatment of primary hypertension? A meta-analysis[J].Lancet,2005,366(9496):1545-1553.
-
3[4]Khan N,McAlister FA.Re-examining the efficiency of β-blockers for treatment of hypertension:a recta-analysis review[J].CMAJ,2006,174(12):1737-1742.
同被引文献48
-
1詹小娜.曲美他嗪对缺血性心肌病左室功能的疗效观察[J].中国医刊,2007,42(11):53-54. 被引量：9
-
2Kereiakes DJ.Reassessing the importance of complete versus incomplete coronary revascularization[J].Rev Cardiovasc Med,2014,15(1):24-30.
-
3翁明翰,陈珠.活心丹治疗缺血型心脏病疗效观察[J].广东医学,1982,3(10):29-31.
-
4Kalra DK,Zoghbi WA.Myocardial hibernation in coronary artery disease[J].Curr Atheroscler Rep,2002,4(2):149-155.
-
5Bukachi F,Clague JR,Waldenstrm A,et al.Clinical outcome of coronary angioplasty in patients with ischaemic cardiomyopathy[J].Int J Cardiol,2003,88(2-3):167-174.
-
6Hobbs FD,Roalfe AK,Davis RC,et al.Prognosis of all case heart failure and borderling left ventricular systolic dysfunction:5-year mortality follow-up of the Echocardiographic Heart of England Screening Study(ECHOES)[J].Eur Heart J,2007,28(9):1128-1134.
-
7Jedrzkiewicz S,Goodman SG,Yan RT,et al.Evaluation of left ventricular ejection in non-ST-segment elevation acute coronary syndromes and its relationship to treatment[J].Am Heart J,2010,159(4):605-611.
-
8Fitzgibbons TP,Meyer TE,Aurigemma GP.Mortality in diastolic heart failure:an update[J].Cardiol Rev,2009,17(2):51-55.
-
9Fukuda S,Hozumi T,Watanabe H,et al.Usefulness of contrast echocardiography to improve the feasibility and accuracy of automated measurements of left ventricular volume and ejection fraction in patients with coronary artery disease[J].Am J Cardiol,2003,92(1):71-74.
-
10Zabalgoitia M,Berning J,Koren MJ,et al.Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy(the LIFE study)[J].Am J Cardiol,2001,88(6):646-650.
二级引证文献3
-
1苏军岭.健脾和胃方治疗冠心病的疗效[J].深圳中西医结合杂志,2021,31(12):63-65.
-
2惠稼祺,信琪琪,袁蓉,缪宇,徐凤芹,丛伟红.活心丸治疗心血管疾病的研究进展[J].天津中医药大学学报,2022,41(3):397-401. 被引量：5
-
3刘德晓,朱可云,梁转合,周荣辉,罗翊芝.活心丸对急性心肌梗死经皮冠状动脉介入术后心绞痛临床疗效观察[J].医学理论与实践,2023,36(16):2739-2742.
-
1韦宁,廖艺,盘红梅.罗格列酮对心血管疾病及其危险因素的影响[J].中国医院药学杂志,2009,29(14):1215-1218. 被引量：1
-
2辛彩虹,李峥,洛伟光,王楠,旷劲松,薛晓馥.维格列汀联合二甲双胍对超重2型糖尿病患者心血管疾病危险因素的干预作用[J].解放军医药杂志,2015,27(8):83-87. 被引量：15
-
3肖长长,姜惠芳,骆九源,胡志辉,罗忠明,刘兰霞,李桂兰,张月.吡格列酮对血液透析患者心血管疾病危险因素的影响[J].中国药物评价,2015,32(1):28-30.
-
4王吉云（摘）.Lipitor适应症扩大[J].国外药讯,2006(2):13-13.
-
5郭绍贞.雌激素与心血管疾病危险因素[J].医药论坛杂志,1995,6(9):52-54.
-
6贡联兵,庞浩龙.调脂药物临床合理应用[J].人民军医,2011,54(9):827-828. 被引量：6
-
7金启辉.多沙唑嗪的独特性[J].中国男科学杂志,2007,21(3):69-69.
-
8胆固醇吸收抑制剂出现了[J].中国家庭医生,2010(21):51-51.
-
9Antman EM,Bennett JS,Daugherty A,蒋晖（摘译）.美国心脏学会更新心脏病患者非甾体类抗炎药使用建议[J].心血管病学进展,2007,28(3):508-508.
-
10李旭,王兵,秦惠基.降脂药临床用药评价[J].医药导报,1996,15(5):253-254. 被引量：2
